Windward Bio

Business Services · Switzerland · 1-10 Employees

View Company Info for Free

Overview

Headquarters

Aeschenplatz 6, Basel, Basel-City, 4052,...

Website

www.windwardbio.com

Revenue

<$5 Million

Industry

Business Services Research & Development
ZI Rank: 1
Signal Type
Mar
Apr
May
Jun
Jul
Aug
ZI Rank
1
1
1
1
1
1

About Windward Bio

Windward Bio is a clinical-stage, drug development company committed to improving outcomes for people living with advanced immunological diseases with an initial focus on severe respiratory conditions. The company is led by a highly experienced team of biopharmaceutical executives with deep discovery, development, and commercialization expertise. The company is advancing a potential best-in-class thymic stromal lymphopoietin (TSLP) monoclonal antibody into phase 2 development and creating novel, long-acting bispecific programs for immunological diseases.Explore more
Windward Bio's Social MediaPopular SearchesWindward Bio AGSIC Code 87,873NAICS Code 54,541Show more

Windward Bio Org Chart

PhoneEmail
Kevin Harris, Chief Operating Officer at Windward Bio
Switzerland flag for contact location.
Kevin Harris

Chief Operating Officer

PhoneEmail
SA
Switzerland flag for contact location.

Chief Legal & Business Officer

PhoneEmail

PhoneEmail
Get the full picture
Sign in to uncover key details.

Is Windward Bio your ideal customer?

Let us give you the heads up on whether it's a good time to reach out

Last 7 days

Congratulate Masked Content for being promoted to Masked Content at Windward Bio

Click to see if Windward Bio had a recent Job posting/layoffs

Product Launch: Get notified when Windward Bio launches new products

Funding: Get notified immidiatlly once Windward Bio has new funding data

Competitive Alert! Recent activity has been detected by your competitor Masked Content

Check if Windward Bio has recently received funding, and reach out quickly before it becomes old news!

Windward Bio, which may be a good buyer, showed buying intent in Masked Content Topic

Website visits: Recent activity has been detected on your website

Earning: See what the market has to say on Windward Bio recently announced quarterly report

Check out if Windward Bio is spiking on competitors!

Recommended Actions

Find VP level buyers at Windward Bio

Find 2 more new buyers

Illustration of an envelope

Company Profile Activity

i

Among all Business Services companies

Low Activity

High Activity

Activity Insights

Windward Bio is experiencing very low activity levels compared to other companies in the Business Services sector.

What does this means?

Windward Bio is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Windward Bio.

Windward Bio financials insights

Gather financial insights about Windward Bio, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.

2025

Series A

$200M

2026

Other Financing Round

$165M

See All Windward Bio's Financials Insights

Most Recent Scoops

Project
Windward Bio is sponsoring an interventional clinical trial focused on assessing WIN378 safety, tolerability, PK and PD in moderate-severe COPD. The trial began on June 2026 with the expected completion date of January 2028. The trial is currently recruiting participants.
Laboratory Operations, Medical Research, Clinical Operations
Funding
Windward Bio has secured $165 million in additional funding. Investors included OrbiMed, RA Capital Management, Janus Henderson investors, Sanofi Ventures, Harbour BioMed, Novo Holdings, and several others.
Funding
Project
Windward Bio is sponsoring an interventional clinical trial focused on evaluating WIN378 safety, pharmacology, and efficacy in moderate to severe asthma. The trial began on July 2025 with the expected completion date of October 2027. The trial is currently in phase two.
Laboratory Operations, Medical Research, Clinical Operations
Funding
Windward Bio has secured $200 million in Series A funding. The round was led by OrbiMed, Novo Holdings, and Blue Owl Healthcare Opportunities, and included participation from investors SR One, Omega Funds, RTW Investments, and others.
Funding
Partnership
Partnership, Research & Development, Product Management, Intellectual Property, Legal Affairs, Medical Research, Pharmaceuticals
See more scoops

Top Business Services Companies

Top companies in Canada by revenue

KGK Science
Horizon Lab
Le Blossom
Douglas Bell Canada Brain Bank
The CRIM
View Full List

Top companies in Australia by revenue

UMCCR Genomics Platform Group
WEHI
ARC Centre of Excellence for Dark Matter Particle Physics
GreenLight Clinical
OMC
View Full List

Top companies in New Zealand by revenue

Avertana
Pipe Spec NZ
SC BIO
Beacon Pathway
Neutral Inspection Services
View Full List
See more top companies

Frequently Asked Questions Regarding Windward Bio

What is Windward Bio's official website?
Windward Bio's official website is www.windwardbio.com What is Windward Bio's Revenue?
Windward Bio's revenue is <$5 Million What is Windward Bio's SIC code?
Windward Bio's SIC: 87,873 What is Windward Bio's NAICS code?
Windward Bio's NAICS: 54,541 How many employees does Windward Bio have?
Windward Bio has 1-10 employees What industry does Windward Bio belong to?
Windward Bio is in the industry of: Business Services, Research & Development What does Windward Bio do?

Windward Bio is a clinical-stage, drug development company committed to improving outcomes for people living with advanced immunological diseases with an initial focus on severe respiratory conditions. The company is led by a highly experienced team of biopharmaceutical executives with deep discovery, development, and commercialization expertise. T... he company is advancing a potential best-in-class thymic stromal lymphopoietin (TSLP) monoclonal antibody into phase 2 development and creating novel, long-acting bispecific programs for immunological diseases.Read More

 What are Windward Bio social media links?
Windward Bio Linkedin page Who invested in Windward Bio?
Windward Bio has 22 investors including OrbiMed, RTW Investments, Blue Owl Healthcare Communications and Qiming Venture Partners. Is Windward Bio a public company?
Windward Bio is private company therefore does not currently have an official ticker symbol
See more information about Windward Bio

Get Started with ZoomInfo

Register for free

Sign Up for Free

Get started for free! No credit card needed. Enjoy up to 25 free contacts each month at no cost.
Elevate your prospecting to the next level

Supercharge Your Prospecting

Search ZoomInfo's database of 106M+ companies and 140M+ professionals to find your next lead.
Expand your business

Grow Your Business

Reveal both personal and business contact details, including emails and phone numbers, and close your most valuable buyers.

Test Drive ZoomInfo's Directories

Browse Directories

Most Searched Industries

Construction Law Firms & Legal Services Business Services Finance Manufacturing Agriculture Software Accounting & Accounting Services Retail Healthcare Energy, Utilities & Waste Treatment Telecommunications Transportation Real Estate
People SearchCompany Search